Terms: = Skin cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
251 results:
1. Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations.
Liu D; Cao M; Wang H; Cao W; Zheng C; Li Y; Wang Y
BMC Med; 2024 Mar; 22(1):137. PubMed ID: 38528540
[TBL] [Abstract] [Full Text] [Related]
2. Linear IgA bullous dermatosis associated with immunotherapy.
Momin B; Nguyen TF; Glade D; Messer A
Dermatol Online J; 2023 Dec; 29(6):. PubMed ID: 38478666
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy.
Wan Q; Deng Y; Wei R; Ma K; Tang J; Deng YP
Aging (Albany NY); 2024 Mar; 16(5):4518-4540. PubMed ID: 38475660
[TBL] [Abstract] [Full Text] [Related]
4. Dermatologic manifestations in pediatric patients with inflammatory bowel disease.
Afarideh M; Bartoletta K; Tollefson MM
Pediatr Dermatol; 2024; 41(2):234-242. PubMed ID: 38326222
[TBL] [Abstract] [Full Text] [Related]
5. Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS inflammation.
Bjursten S; Zhao Z; Al Remawi H; Studahl M; Pandita A; Simrén J; Zetterberg H; Lundell AC; Rudin A; Ny L; Levin M
EBioMedicine; 2024 Feb; 100():104955. PubMed ID: 38171113
[TBL] [Abstract] [Full Text] [Related]
6. Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Bafaloukos D; Kouzis P; Gouveris P; Boukovinas I; Kalbakis K; Baka S; Kyriakakis G; Moschou D; Molfeta A; Demiri S; Mavroudis D; Spanoudi F; Dimitriadis I; Gogas H
Melanoma Res; 2024 Apr; 34(2):152-165. PubMed ID: 38092014
[TBL] [Abstract] [Full Text] [Related]
7. Mycosis fungoides with spongiosis: a case report.
Kashabano JJ; Rugengamazi E; Matiku SB; Mruma RM; Lugina EL
J Med Case Rep; 2023 Nov; 17(1):458. PubMed ID: 37919795
[TBL] [Abstract] [Full Text] [Related]
8. Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).
Ascierto PA; Agarwala SS; Warner AB; Ernstoff MS; Fox BA; Gajewski TF; Galon J; Garbe C; Gastman BR; Gershenwald JE; Kalinski P; Krogsgaard M; Leidner RS; Lo RS; Menzies AM; Michielin O; Poulikakos PI; Weber JS; Caracò C; Osman I; Puzanov I; Thurin M
J Transl Med; 2023 Jul; 21(1):508. PubMed ID: 37507765
[TBL] [Abstract] [Full Text] [Related]
9. Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma.
Frenard C; Blanchet K; Lecerf P; Varey E; Khammari A; Dréno B
Eur J Dermatol; 2023 Apr; 33(2):75-80. PubMed ID: 37431109
[TBL] [Abstract] [Full Text] [Related]
10. Medical application of laser-induced breakdown spectroscopy (LIBS) for assessment of trace element and mineral in biosamples: Laboratory and clinical validity of the method.
Skalny AV; Korobeinikova TV; Aschner M; Baranova OV; Barbounis EG; Tsatsakis A; Tinkov AA
J Trace Elem Med Biol; 2023 Sep; 79():127241. PubMed ID: 37393771
[TBL] [Abstract] [Full Text] [Related]
11. Sclerosing mesenteritis following immune checkpoint inhibitor therapy.
Kuang AG; Sperling G; Liang TZ; Lu Y; Tan D; Bollin K; Johnson DB; Manzano JM; Shatila M; Thomas AS; Thompson JA; Zhang HC; Wang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9221-9227. PubMed ID: 37195298
[TBL] [Abstract] [Full Text] [Related]
12. Managing metastatic Crohn's disease: a single center experience, review of the current evidence, and treatment algorithm.
Beysens S; Wellens J; De Hertogh G; Van Laethem A; Sabino J; Hillary T; Vermeire S
Scand J Gastroenterol; 2023; 58(10):1122-1130. PubMed ID: 37178009
[TBL] [Abstract] [Full Text] [Related]
13. Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events.
Müller B; Bärenwaldt A; Herzig P; Zippelius A; Maul LV; Hess V; König D; Läubli H
Front Immunol; 2023; 14():1125111. PubMed ID: 37122748
[TBL] [Abstract] [Full Text] [Related]
14. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
Franklin C; Mohr P; Bluhm L; Meier F; Garzarolli M; Weichenthal M; Kähler K; Grimmelmann I; Gutzmer R; Utikal J; Terheyden P; Herbst R; Haferkamp S; Pfoehler C; Forschner A; Leiter U; Ziller F; Meiss F; Ulrich J; Kreuter A; Gebhardt C; Welzel J; Schilling B; Kaatz M; Scharfetter-Kochanek K; Dippel E; Nashan D; Sachse M; Weishaupt C; Löffler H; Gambichler T; Loquai C; Heinzerling L; Grabbe S; Debus D; Schley G; Hassel JC; Weyandt G; Trommer M; Lodde G; Placke JM; Zimmer L; Livingstone E; Becker JC; Horn S; Schadendorf D; Ugurel S
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37028819
[TBL] [Abstract] [Full Text] [Related]
15. Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations.
Park BC; Narayanan S; Gavraldis A; Ye F; Fan R; Sullivan RJ; Boland G; Reynolds KL; Balko JM; Carlino MS; Long GV; Zubiri L; Menzies AM; Johnson DB
Oncoimmunology; 2023; 12(1):2188719. PubMed ID: 36926262
[TBL] [Abstract] [Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm: a diagnosis not to be missed, about three case reports.
Fakhfakh Y; Ben Aribia N; Mnif S; Sannenna H; Mnif H; Louati N
Tunis Med; 2022; 100(8-9):647-651. PubMed ID: 36571733
[TBL] [Abstract] [Full Text] [Related]
17. Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.
Mahajna H; Verstockt B; Bergemalm D; Castiglione F; Rodríguez-Moranta F; Savarino E; Hoentjen F; Bessissow T; Pokryszka J; Cremer A; Eder P; Truyens M; Yerushalmy-Feler A; García MJ; Kopylov U
J Crohns Colitis; 2023 May; 17(5):722-727. PubMed ID: 36455965
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemical expression of p53, Ki67, α-SMA, CD44 and CD31 in different histological subtypes of basal cell carcinoma.
Cojocaru A; Bîrjovanu C; Ciurea AM; Niculescu D; Orzan OA; Ion A; Alexandru DO; Pirici I; Vîlcea EJ; Marinescu EA; Ciurea ME
Rom J Morphol Embryol; 2022; 63(2):383-393. PubMed ID: 36374143
[TBL] [Abstract] [Full Text] [Related]
19. Iris melanoma outcomes based on the cancer Genome Atlas (TCGA) classification in 78 consecutive patients.
Cherkas E; Negretti GS; Zeiger JS; Shields CL
Ophthalmic Genet; 2022 Dec; 43(6):736-741. PubMed ID: 36326016
[TBL] [Abstract] [Full Text] [Related]
20. Basal cell carcinoma-clinico-pathological study in Eastern India in correlation with different risk factors.
Jain C; Garg N; Singh S; Chattopadhyay S
Indian J Pathol Microbiol; 2022; 65(4):869-872. PubMed ID: 36308196
[TBL] [Abstract] [Full Text] [Related]
[Next]
